Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
LAVA Therapeutics N.V. (LVTX) had Income from Continuous Operations of $-8.64M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-8.64M |
|
-- |
|
-- |
|
$7.29M |
|
$-7.29M |
|
$-1.28M |
|
$-8.57M |
|
$-8.57M |
|
$-8.64M |
|
|
Income from Continuous Operations |
$-8.64M |
$-8.64M |
|
$-8.64M |
|
$-7.29M |
|
$-7.83M |
|
26.90M |
|
26.90M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$60.49M |
|
$0.04M |
|
$0.05M |
|
$60.55M |
|
$5.61M |
|
-- |
|
$35.00M |
|
$40.61M |
|
$19.93M |
|
$19.93M |
|
$19.93M |
|
26.30M |
|
| Cash Flow Statement Financials | |
$-25.39M |
|
$12.66M |
|
-- |
|
$35.02M |
|
$26.38M |
|
$-8.63M |
|
$0.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-43.34% |
|
-43.34% |
|
-14.27% |
|
-43.34% |
|
$0.76 |
|
$-0.93 |
|
$-0.94 |
|